Director/PDMR Shareholding

GlaxoSmithKline PLC 11 July 2006 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 11 July 2006 of an increase in their notional interests in Ordinary Shares at a price of £15.40 per share and Ordinary Share ADRs at a price of $57.17 per ADR following the notional re-investment of the dividend paid to shareholders on 6 July 2006. Dr JP Garnier 2,919.696 ADRs Mr J Heslop 115.331 Ordinary shares Dr M Slaoui 277.800 Ordinary shares Mr R Bondy 1,168.107 Ordinary shares Dr F Calhoun 364.962 ADRs Mr J Clarke 747.923 Ordinary shares Mr M Dunoyer 439.936 Ordinary shares Dr R Greig 364.962 ADRs Mr D Learmouth 81.230 Ordinary shares Mr D Phelan 562.041 ADRs Dr D Pulman 386.476 Ordinary shares 179.037 ADRs Mr D Stout 1,080.287 ADRs Mr C Viehbacher 562.041 ADRs Mr A Witty 1,028.975 Ordinary shares The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period. This notification relates to a transaction notified in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b). S M Bicknell Company Secretary 11 July 2006 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100